menu
    • menu

    Company profile for Neurocrine Biosciences

    NEW Drugs in Dev: 31
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical company with more than 25 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia and endometriosis* and clinical development program...
    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical company with more than 25 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia and endometriosis* and clinical development programs in multiple therapeutic areas including Parkinson’s disease, congenital adrenal hyperplasia and uterine fibroids*.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neurocrine BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego, CA 92130
    Telephone
    Telephone
    1-858-617-7600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurocrine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neurocrine Biosciences Starts Phase 2 Trial For NBI-1065890
    Neurocrine Biosciences Starts Phase 2 Trial For NBI-1065890

    26 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-initiates-phase-2-clinical-study-evaluating-nbi-1065890-in-adults-with-tardive-dyskinesia-302669338.html

    PR NEWSWIRE BIO
    26 Jan 2026
    Share Share
    Neurocrine Biosciences Announces Q4 2025 Earnings
    Neurocrine Biosciences Announces Q4 2025 Earnings

    21 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-fourth-quarter-and-year-end-2025-financial-results-302667190.html

    PR NEWSWIRE
    21 Jan 2026
    Share Share
    Neurocrine Biosciences Shows INGREZZA Outperforms AUSTEDO XR
    Neurocrine Biosciences Shows INGREZZA Outperforms AUSTEDO XR

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-head-to-head-ingrezza-valbenazine-capsules-data-demonstrating-higher-vmat2-target-occupancy-compared-to-austedo-xr-302661800.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    Neurocrine Biosciences at 44th J.P. Morgan Healthcare Conference
    Neurocrine Biosciences at 44th J.P. Morgan Healthcare Conference

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302653067.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Neurocrine's Movement Disorder Treatment Fails Late-Stage Trial
    Neurocrine's Movement Disorder Treatment Fails Late-Stage Trial

    23 Dec 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/neurocrines-valbenazine-fails-phase-iii-neurodevelopmental-disorder-trial

    BIOSPACE
    23 Dec 2025
    Share Share
    Neurocrine Biosciences Highlights R&D Transformation
    Neurocrine Biosciences Highlights R&D Transformation

    16 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-showcases-rd-transformation-driving-innovation-across-neuroscience-and-endocrinology-302643635.html

    PR NEWSWIRE
    16 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search